Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05877508Phase 2Active Not Recruiting
Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
Long COVIDPost-Acute COVID-19Post-Acute Sequela of COVID-19
PrincipalinvestigatorStart date: 2023-08-01
NCT04362150Recruiting
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
COVID
PrincipalinvestigatorStart date: 2020-04-21

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05877508Phase 2PrincipalInvestigator

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

Long COVIDPost-Acute COVID-19Post-Acute Sequela of COVID-19
Active Not Recruiting
NCT04362150PrincipalInvestigator

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

COVID
Recruiting

All 2 trials loaded